ArticleMolecular cancer therapeutics2010

Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Vanessa Fritz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.